Senior insider sale
Chief Commercial Officer at BETA BIONICS, INC. — senior position signals high conviction
$434.0K
20.29K shares
What this filing means
HOPMAN MARK plans to sell 20.29K shares of BETA BIONICS, INC. valued at approximately $434.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/4/2025ACC: 0001628280-25-055396
Officer· Chief Commercial Officer
Since Mar 2026
20.29K
Shares to sell
$434.0K
Approx. market value
2.06K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Equity Award
Cash
12/1/2025
2.06KTotal acquired2.06K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
12/1/2025 | Equity Award Cash | 2.06K | — |
| Total | 2.06K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
11.41K
Market value
$234.7K
9/5/2025
—Completed
Units to sell
6.82K
Market value
$136.2K
9/4/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
2.06K
Market value
$63.2K
12/4/2025
Total
Units
20.29K
Value
$434.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
9/5/2025 | 11.41K | $234.7K | — | Completed |
9/4/2025 | 6.82K | $136.2K | — | Completed |
| Planned — Approximate Date | ||||
12/4/2025 | 2.06K | $63.2K | NASDAQ | Planned |
| Total | 20.29K | $434.0K | ||